Natrunix

Drug identity checked against registry records

Also recorded as True Human IgG4 monoclonal antibody

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Natrunix or Placebo in Combination With Methotrexate in Rheumatoid ArthritisNCT05363891XBITPhase 2Completed2024-10-31Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.